How Much Does Jatenzo Cost in Utah in 2026?

Utah Retail Pricing for Jatenzo

The average cash-pay price for Jatenzo across Utah retail pharmacies sits at roughly $900 per month in 2026, matching the Tolmar manufacturer list price. That number reflects the wholesale acquisition cost passed through to patients without insurance coverage or discount programs.

Pricing variation between Utah pharmacies is minimal for brand-name Jatenzo because no generic competitor exists. Chains like CVS, Walgreens, and Harmons Pharmacy in the Salt Lake City metro area all price within a narrow band of the list price. Independent pharmacies occasionally offer modest discounts, but savings rarely exceed 5-8% without a coupon or manufacturer program.

Jatenzo received FDA approval in March 2019 as the first oral testosterone undecanoate product for adult males with conditions associated with a deficiency or absence of endogenous testosterone. The key registration trial by Swerdloff et al. (2020) enrolled 166 hypogonadal men and demonstrated that 87% of patients achieved average serum testosterone concentrations within the normal range (300-1 to 100 ng/dL) at the final titrated dose. The drug uses a self-emulsifying formulation absorbed through the intestinal lymphatic system, bypassing first-pass hepatic metabolism. This pharmacokinetic design distinguishes it from older oral methyltestosterone products, which carried hepatotoxicity risks that led the Endocrine Society to recommend against their use.

Price transparency matters. Utah's Right to Shop Act (Utah Code 49-20-508) encourages state employees to compare procedure and medication costs, but Jatenzo's single-source status limits competitive pressure on pricing.

Insurance Coverage in Utah

Most commercial insurance plans in Utah will cover Jatenzo, but nearly all require prior authorization and a confirmed diagnosis of male hypogonadism with two morning serum testosterone levels below 300 ng/dL.

The Endocrine Society's 2018 clinical practice guideline defines the diagnostic threshold and recommends testosterone replacement therapy (TRT) for men with unequivocally low testosterone and consistent signs or symptoms. Insurers in Utah, including SelectHealth, Regence BlueCross BlueShield of Utah, and Molina Healthcare, follow these diagnostic criteria when adjudicating prior authorization requests.

Step therapy is common. Several Utah plans require documentation that the patient has tried or has a contraindication to injectable testosterone (cypionate or enanthate) before approving Jatenzo. Injectable testosterone cypionate costs between $30 and $90 per month, making it the default first-line option from a payer perspective. Patients who demonstrate needle phobia, injection-site reactions, or adherence failure with injectables have a stronger case for oral Jatenzo approval.

PEHP (Public Employees' Health Program), which covers approximately 170,000 Utah state employees and dependents, lists testosterone products on its formulary but applies quantity limits and prior authorization to oral formulations. Checking PEHP's current formulary before submitting a prior authorization request can save weeks of back-and-forth.

Copay tiers vary. On plans that do cover Jatenzo, it typically falls on a specialty or non-preferred brand tier, meaning copays of $75 to $150 per month for commercially insured patients before any manufacturer discount is applied.

Utah Medicaid and Jatenzo

Utah Medicaid does not cover Jatenzo. The state's Medicaid preferred drug list excludes oral testosterone undecanoate entirely as of early 2026.

This exclusion aligns with a cost-containment strategy. Utah Medicaid covers injectable testosterone cypionate and topical testosterone (AndroGel, Testim, and their generics) as preferred agents, both of which cost the state significantly less per member per month. Injectable testosterone cypionate, for example, costs Medicaid programs approximately $20-40 per month at Average Acquisition Cost.

For Medicaid-enrolled patients who cannot use injectables or topicals, providers can submit a prior authorization exception request to the Utah Department of Health and Human Services. Approval rates for exception requests on non-formulary brand medications are low. The request must document clinical failure or intolerance of at least two preferred alternatives, and the prescriber should include specific clinical notes describing the adverse reaction or barrier.

Patients transitioning off Medicaid (for instance, after the post-pandemic Medicaid unwinding) who were not previously eligible for Jatenzo should explore commercial plan options or manufacturer assistance before assuming the full cash-pay price.

The Tolmar Savings Card

Tolmar Pharmaceuticals, which markets Jatenzo, offers a savings card that can reduce monthly out-of-pocket costs to as low as $0 for commercially insured patients, depending on their plan's copay structure.

The savings card covers up to a set dollar amount per prescription fill. Exact benefit amounts change periodically, so patients should verify current terms at the manufacturer's website or by calling the number on the card. The card is not valid for patients covered by any federal healthcare program, including Medicare, Medicaid, TRICARE, or VA benefits. This federal exclusion is mandated by the Anti-Kickback Statute, not by Tolmar's choice.

To use the Tolmar savings card at a Utah pharmacy, patients present the card at the point of sale alongside their commercial insurance card. The pharmacy processes the insurance claim first, then applies the savings card to the remaining copay or coinsurance. Patients enrolled in high-deductible health plans (HDHPs) should note that manufacturer copay cards do not count toward deductible accumulation under most plan designs. This means you could pay $0 per month for Jatenzo with the card but still face a large deductible when filling other prescriptions.

Enrollment is straightforward. Patients can register online, receive a digital card, and present it at any participating Utah pharmacy. There is no income verification requirement.

Compounded Oral Testosterone Undecanoate in Utah

Licensed 503A compounding pharmacies in Utah can legally prepare oral testosterone undecanoate for individual patients with valid prescriptions. This is a lower-cost alternative to brand Jatenzo.

503A pharmacies operate under Section 503A of the Federal Food, Drug, and Cosmetic Act and are regulated by the Utah Division of Occupational and Professional Licensing (DOPL). They compound medications on a patient-specific basis, meaning each prescription is filled for an identified patient with a prescriber's order. Utah does not prohibit the compounding of testosterone undecanoate, provided the pharmacy holds a valid Utah compounding license and the drug is not an exact copy of a commercially available product in the same dosage form. This "essentially a copy" rule creates a gray area. The FDA has taken the position that a compounded product is an "essentially a copy" if it is the same active ingredient, route of administration, and dosage form as an approved drug. However, compounding pharmacies often argue that differences in excipients, capsule composition, or dose strength distinguish their products.

Cost is the primary driver. Compounded oral testosterone undecanoate from a Utah 503A pharmacy can cost substantially less than brand Jatenzo, with some pharmacies pricing 30-day supplies in the range of $100 to $300 depending on dose and formulation.

A clinical caveat: Jatenzo's FDA-approved formulation uses a proprietary self-emulsifying drug delivery system (SEDDS) that enhances lymphatic absorption. Compounded versions may not replicate this absorption profile. The Swerdloff et al. trial validated pharmacokinetics for the branded formulation specifically. Patients switching from Jatenzo to a compounded product should have serum testosterone levels rechecked 2 to 4 weeks after the switch to confirm adequate absorption.

Several Utah compounding pharmacies with 503A licenses serve the Wasatch Front area, including options in Salt Lake City, Provo, and Ogden. Patients in rural Utah can often obtain compounded prescriptions via mail from licensed in-state pharmacies.

Telehealth Access to Jatenzo in Utah

Utah permits telehealth prescribing of Jatenzo. The state's telehealth parity law (Utah Code 26-60) allows providers licensed in Utah to prescribe Schedule III controlled substances, including testosterone, via audio-video telehealth visits.

Testosterone products are classified as Schedule III controlled substances under the Controlled Substances Act. Utah follows the federal Ryan Haight Act requirement that an initial prescription for a controlled substance via telehealth generally requires a DEA-registered practitioner to conduct a real-time, two-way interactive audio-video consultation. Subsequent refill visits can also occur via telehealth.

Telehealth TRT clinics operating in Utah include national platforms and Utah-based practices. The diagnostic workup still requires laboratory testing. Patients need two morning serum total testosterone levels drawn at a local lab (Quest, LabCorp, or hospital lab) before a telehealth prescriber can diagnose hypogonadism and prescribe Jatenzo. The American Urological Association's 2018 guideline recommends confirming low testosterone on at least two separate morning samples, collected before 10:00 AM.

For Utah patients in rural areas. Telehealth eliminates the need to drive to a specialist in Salt Lake City or Provo. Endocrinologists and urologists concentrated along the Wasatch Front can see patients statewide through telehealth, and primary care providers comfortable with TRT management can also prescribe.

Patients should confirm that their telehealth provider's pharmacy network includes Utah pharmacies that stock Jatenzo or can order it. Specialty pharmacies generally ship within one to two business days to Utah addresses.

Comparing Jatenzo to Other TRT Options in Utah

Jatenzo is the only FDA-approved oral testosterone for hypogonadism, but several other formulations are available in Utah at different price points.

Injectable testosterone cypionate remains the most affordable option at $30 to $90 per month cash price, administered via intramuscular or subcutaneous injection every 1 to 2 weeks. Topical testosterone gels (generic AndroGel 1.62%) cost approximately $80 to $200 per month. Testosterone nasal gel (Natesto) runs approximately $500 to $700 per month. Testosterone pellets (Testopel) cost $500 to $1,500 per insertion, performed every 3 to 6 months.

The clinical advantage of Jatenzo is convenience. No needles, no skin transfer risk (a concern with gels, especially for patients with young children or female partners), and no office procedures. The FDA label notes that Jatenzo must be taken with food to ensure adequate absorption, as fat content in meals drives lymphatic uptake. Taking Jatenzo on an empty stomach reduces bioavailability by approximately 50%, according to pharmacokinetic data in the prescribing information.

Blood pressure monitoring is required. The FDA mandated a Risk Evaluation and Mitigation Strategy (REMS) for Jatenzo due to dose-dependent increases in systolic blood pressure observed in clinical trials. In the Swerdloff et al. study, mean systolic blood pressure increased by 3-5 mmHg in treated patients. The REMS requires that prescribers be certified and that pharmacies be enrolled, which can limit which Utah pharmacies dispense the drug.

A 2021 analysis published in the Journal of the Endocrine Society estimated annual per-patient TRT costs across formulations and found oral testosterone undecanoate to be the most expensive option by a factor of 5 to 10 compared to generic injectable testosterone cypionate.

Tips for Reducing Jatenzo Costs in Utah

Start with insurance. Even if your plan requires step therapy, completing the prior authorization process is worth the effort because approved coverage drops monthly costs to a copay rather than the full $900.

Stack the Tolmar savings card on top of commercial insurance. If your copay after insurance is $100, the savings card may eliminate it entirely.

Ask your prescriber about compounded oral testosterone undecanoate from a Utah 503A pharmacy if cost is a barrier and you prefer oral dosing. Confirm that the compounding pharmacy tests potency and sterility per USP <795> standards.

Check GoodRx, RxSaver, and SingleCare coupons at Utah pharmacies. These aggregators occasionally negotiate rates below list price, though discounts on brand-only products like Jatenzo tend to be modest (5-15%).

If you are a veteran, the VA formulary covers injectable and topical testosterone but generally does not cover Jatenzo. VA patients seeking oral TRT should discuss options with their VA prescriber.

For uninsured patients, Tolmar's patient assistance program may provide Jatenzo at no cost to qualifying individuals. Eligibility typically requires household income below 300-400% of the federal poverty level and no other prescription drug coverage.

The most reliable long-term cost reduction strategy: get a confirmed diagnosis, complete step therapy documentation, and work with your prescriber's office to submit a thorough prior authorization. Approval rates increase when the clinical rationale clearly documents why alternatives failed.